1. Home
  2. MDAI vs VRAR Comparison

MDAI vs VRAR Comparison

Compare MDAI & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAI
  • VRAR
  • Stock Information
  • Founded
  • MDAI 2013
  • VRAR 2016
  • Country
  • MDAI United States
  • VRAR United States
  • Employees
  • MDAI N/A
  • VRAR N/A
  • Industry
  • MDAI Medical/Dental Instruments
  • VRAR Retail: Computer Software & Peripheral Equipment
  • Sector
  • MDAI Health Care
  • VRAR Technology
  • Exchange
  • MDAI Nasdaq
  • VRAR Nasdaq
  • Market Cap
  • MDAI 27.8M
  • VRAR 26.9M
  • IPO Year
  • MDAI N/A
  • VRAR 2021
  • Fundamental
  • Price
  • MDAI $1.29
  • VRAR $1.20
  • Analyst Decision
  • MDAI Strong Buy
  • VRAR Strong Buy
  • Analyst Count
  • MDAI 2
  • VRAR 1
  • Target Price
  • MDAI $4.75
  • VRAR $4.67
  • AVG Volume (30 Days)
  • MDAI 426.7K
  • VRAR 149.9K
  • Earning Date
  • MDAI 05-06-2025
  • VRAR 05-14-2025
  • Dividend Yield
  • MDAI N/A
  • VRAR N/A
  • EPS Growth
  • MDAI N/A
  • VRAR N/A
  • EPS
  • MDAI N/A
  • VRAR N/A
  • Revenue
  • MDAI $29,581,000.00
  • VRAR $9,230,197.00
  • Revenue This Year
  • MDAI N/A
  • VRAR $39.02
  • Revenue Next Year
  • MDAI $49.47
  • VRAR N/A
  • P/E Ratio
  • MDAI N/A
  • VRAR N/A
  • Revenue Growth
  • MDAI 63.83
  • VRAR N/A
  • 52 Week Low
  • MDAI $0.82
  • VRAR $0.50
  • 52 Week High
  • MDAI $3.25
  • VRAR $7.00
  • Technical
  • Relative Strength Index (RSI)
  • MDAI 39.65
  • VRAR 42.23
  • Support Level
  • MDAI $1.04
  • VRAR $1.10
  • Resistance Level
  • MDAI $1.76
  • VRAR $1.33
  • Average True Range (ATR)
  • MDAI 0.16
  • VRAR 0.11
  • MACD
  • MDAI -0.02
  • VRAR 0.01
  • Stochastic Oscillator
  • MDAI 31.65
  • VRAR 29.41

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.

Share on Social Networks: